Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Cycle Strategies For AOD-9604 Peptide AOD9604 is typically run in short cycles rather than continuous year-round use: Cycle Length: 412 weeks, depending on body composition goals Break Periods: Taking 24 weeks off between cycles may help maintain sensitivity and responsiveness Expected Results: Clinical data shows reductions in fat mass may start appearing after 68 weeks of consistent use, but results vary based on diet, training, and metabolic health (trial overview) Stacking AOD9604 with Other Peptides or Supplements Many athletes and clinics stack AOD9604 with other compounds to enhance its fat-burning potential: CJC1295 + Ipamorelin Promotes growth hormone release, potentially amplifying fat-loss effects
Statistical analysis A sample size of 156 participants (104 randomized to survodutide and 52 to placebo) was calculated to provide 90% overall power to demonstrate superiority of survodutide 6.0 mg over placebo for both co-primary endpoints, each at a two-sided significance level of 0.05, assuming an early treatment discontinuation rate of 15%
Weekly medication costs vary significantly across different GLP-1 options
(PubMed) Johansen JS, Harris AK, Rychly DJ, Ergul A
Limited Availability Choice of 1 of 4 primary IV infusions FREE consultation State-of-the-art massage chair or Medical-grade oxygen therapy Claim Your Offer Now Why Use IV Therapy
The two most notorious culprits are Proton Pump Inhibitors (PPIs) , used for acid reflux, and Metformin , the first-line treatment for Type 2 diabetes
